Prof. GÖKHAN METAN

Publication Network

Articles 139

1. In reply to the letter to the editor regarding 'battle of polymyxin induced nephrotoxicity: Polymyxin B versus colistin

BALLI TURHAN F. N., Ekinci P. B., Kurtaran M., KARA E., TELLİ DİZMAN G., SÖNMEZER M. Ç., et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS , vol.66, no.4, 2025 (SCI-Expanded, Scopus)

2. Therapeutic drug monitoring in patients treated with vancomycin: a single center, prospective, observational, real-world study

Dogan C. Z., KARA E., PINAR A., DEMİRKAN S. K., METAN G.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES , vol.44, no.9, pp.2159-2165, 2025 (SCI-Expanded, Scopus) Sustainable Development

3. Posaconazole Therapeutic Drug Monitoring in Daily Practice: A Single-Center Analysis

Balaban U., Kara E., Pinar A., Gülmez Kıvanç D., Karakulak E. A., Akdagli S. A., et al.

INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION , 2025 (SCI-Expanded, Scopus) Sustainable Development

4. Quantitative Immunoglobulin G and Interferon-Gamma Responses After Different Booster Strategies of CoronaVac and BNT162b2 Vaccines in Turkiye

Ocakli A. I., Ozyar-Kurtcu S. A., Uzun M., KAŞIKCI ÇAVDAR M., Telli-Dizman G., METAN G., et al.

INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY , vol.7, no.2, pp.156-165, 2025 (ESCI, TRDizin) Sustainable Development

5. INTRAVENOUS-TO-ORAL SWITCH IN ANTIMICROBIAL THERAPY: A SINGLE-CENTER, OBSERVATIONAL STUDY

Yumrucu F. G., KARA E., İNKAYA A. Ç., METAN G., UZUN Ö.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , vol.47, no.2, pp.499, 2025 (SCI-Expanded, Scopus)

6. Management of Infections Caused by Stenotrophomonas maltophilia: A Traditional Review

Gul Yumrucu F., KARA E., TELLİ DİZMAN G., İNKAYA A. Ç., DEMİRKAN S. K., METAN G.

FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , vol.30, no.1, pp.1-10, 2025 (ESCI, TRDizin)

7. Impact of Aspergillus PCR on the management of invasive aspergillosis: A tertiary care hospital experience during the COVID-19 pandemic

IŞIK M. C., METAN G., ALP A., GÜLMEZ KIVANÇ D., ARIKAN AKDAĞLI S., UZUN Ö.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE , no.3, 2025 (SCI-Expanded, Scopus)

8. The impact of the COVID-19 on the antifungal consumption and antifungal resistance in Candida species isolated from the blood cultures of critically ill patients in intensive care units

KARA E., METAN G., Guelmez D., Arikan-Akdagli S.

MEDICAL MYCOLOGY , vol.63, no.2, 2025 (SCI-Expanded, Scopus) Sustainable Development

9. A scoring system to predict resistance to ceftolozane/tazobactam in respiratory isolates of Pseudomonas aeruginosa

Karadogan E., SERTÇELİK A., TELLİ DİZMAN G., UZAR H., HAZIROLAN G., ÇAKIR B., et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY , no.3, pp.788-796, 2025 (SCI-Expanded, Scopus)

10. Monitoring of the cerebrospinal fluid voriconazole level in a patient with recurrent Candida meningitis after pituitary surgery

Üçdal M. T., Kara E., Berker M., Pınar A., Gulmez D., Arikan-Akdagli S., et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS , no.6, 2024 (SCI-Expanded, Scopus)

11. Predictive modeling of mortality in carbapenem-resistant Acinetobacter baumannii bloodstream infections using machine learning.

Özdede M., Zarakolu P., Metan G., Köseoğlu Eser Ö., Selimova C., Kızılkaya C., et al.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research , vol.72, pp.684-696, 2024 (SCI-Expanded, Scopus)

12. Effect of inflammation on voriconazole levels in patients with invasive pulmonary aspergillosis

BAKIR EKİNCİ P., BAYRAKTAR ALKAN İ., ER A. G., Pinar A., İNKAYA A. Ç., DEMİRKAN S. K., et al.

JOURNAL OF INFECTION IN DEVELOPING COUNTRIES , no.10, 2024 (SCI-Expanded, Scopus)

13. The impact of hospital-specific guidelines on carbapenem use and patient outcomes in a setting for high endemicity with multidrug-resistant gram-negative bacilli

BOŞNAK C., Findik S. B., Atay M., Fakhouri W., Babazade S., Karadogan E., et al.

ANTIMICROBIAL STEWARDSHIP & HEALTHCARE EPIDEMIOLOGY , vol.4, no.1, 2024 (ESCI, Scopus)

14. An Institutional Febrile Neutropenia Protocol Improved the Antibacterial Treatment and Encouraged the Development of a Computerized Clinical Decision Support System

TAŞ Z., METAN G., TELLİ DİZMAN G., Yavuz E., DİZDAR Ö., BÜYÜKAŞIK Y., et al.

ANTIBIOTICS-BASEL , vol.13, no.9, 2024 (SCI-Expanded, Scopus)

15. Optimization of appropriate antimicrobial prophylaxis in general surgery: a prospective cohort study.

Doğan C. Z., Yalçın N., Cennet Ö., Metan G., Demirkan K., Yorgancı K.

European journal of medical research , vol.29, no.1, pp.340, 2024 (SCI-Expanded, Scopus)

16. The Impact of Reporting the Same-Day Identification and Antibiotic Susceptibility Test Results on the Treatment of Bloodstream Infections

DEMİR M., TELLİ DİZMAN G., HAZIROLAN G., UZUN Ö., METAN G.

INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY , vol.6, no.2, pp.123-132, 2024 (ESCI, Scopus, TRDizin) Sustainable Development

17. Battle of polymyxin induced nephrotoxicity: Polymyxin B versus colistin.

BALLI TURHAN F. N., Ekinci P. B., Kurtaran M., KARA E., Dizman G., SÖNMEZER M. Ç., et al.

International journal of antimicrobial agents , vol.63, no.2, pp.107035, 2024 (SCI-Expanded, Scopus)

18. Impact of a hospital sepsis management protocol on the selection of empirical antibiotics in infectious disease consultations

Özden A., Dalgıç B., DEMİR M., HAZIROLAN G., UZUN Ö., METAN G.

Journal of Chemotherapy , vol.36, no.3, pp.190-197, 2024 (SCI-Expanded, Scopus)

19. Diagnostic performance and longitudinal analysis of fungal biomarkers in COVID-19 associated pulmonary aspergillosis

ER B., ER A. G., GÜLMEZ KIVANÇ D., ŞAHİN T. K., METAN G., SARIBAŞ Z., et al.

Heliyon , vol.9, no.11, 2023 (SCI-Expanded, Scopus)

20. Does marking as sterile mean really sterile? Stenotrophomonas maltophilia outbreak caused by a blood-gas injector containing liquid heparin.

Telli Dizman G., Metan G., Karahan G., Tanrıverdi E. S., Hazırolan G., Otlu B., et al.

Infection control and hospital epidemiology , vol.44, pp.1683-1685, 2023 (SCI-Expanded, Scopus)

21. Cessation of Rectal Screening for Vancomycin-Resistant Enterococci: Experience from a Tertiary Care Hospital from Türkiye.

Telli Dizman G., Metan G., Zarakolu P., Tanrıverdi E. S., Hazırolan G., Aytaç Ak H., et al.

Healthcare (Basel, Switzerland) , vol.11, no.19, 2023 (SCI-Expanded, SSCI, Scopus)

22. Evaluation of Cleaning and Disinfection with Fluorescent Marking in Intensive Care Units and Importance of Cross-Monitoring

Telli Dizman G., Metan G., CINAR B., Tekin İ., Zengin H., Akyürek Y., et al.

Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi , vol.28, no.3, pp.466-471, 2023 (ESCI, TRDizin)

23. Knowledge of isolation precautions among the healthcare workers in the emergency department of a university hospital

Sertçelik A., Arslan V., Karadogan E., Uzar H., Cakir B., Metan G.

Acta Medica , vol.54, no.3, pp.241-251, 2023 (TRDizin)

24. Necrotizing pneumonia due to Aspergillus and Salmonella after immune checkpoint inhibitor treatment: An unusual case and review of the literature Neumonía necrotizante por Aspergillus y Salmonella tras tratamiento con un inhibidor de puntos de control inmunitario: un caso inusual y revisión de la literatura

IŞIK M. C., KARCIOĞLU O., HAZIROLAN G., GÜLMEZ KIVANÇ D., ONUR M. R., KUNT M. M., et al.

Revista Iberoamericana de Micologia , vol.40, no.2-3, pp.26-30, 2023 (SCI-Expanded, Scopus)

25. Evaluation of risk factors for developing COVID-19 in healthcare professionals working at two university hospitals in Turkey.

Sertçelik A., Cakir B., Metan G.

Work (Reading, Mass.) , vol.74, no.3, pp.799-809, 2023 (SSCI, Scopus)

26. Lesson learned from the pandemic: Isolation and hygiene measures for COVID-19 could reduce the nosocomial infection rates in oncology wards

GÜVEN D. C., EROĞLU İ., Ismayilov R., ULUSOYDAN E., AKTEPE O. H., TELLİ DİZMAN G., et al.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.28, no.8, pp.1807-1811, 2022 (SCI-Expanded, Scopus) Sustainable Development

27. The guideline compatibility of mucormycosis management: A retrospective review of 165 case reports from European quality (EQUAL) score perspective

Bolek H., METAN G.

JOURNAL DE MYCOLOGIE MEDICALE , vol.32, no.4, 2022 (SCI-Expanded, Scopus)

28. Impact of HLA Polymorphism on the Immune Response to Bacillus Anthracis Protective Antigen in Vaccination versus Natural Infection

Ascough S., Ingram R. J., Chu K. K. Y., Moore S. J., Gallagher T., Dyson H., et al.

VACCINES , vol.10, no.10, 2022 (SCI-Expanded, Scopus)

29. The impact of COVID-19 pandemic on nosocomial multidrug-resistant bacterial bloodstream infections and antibiotic consumption in a tertiary care hospital

Metan G., Cuha M. D., Hazirolan G., Dizman G., Tanriverdi E. S., Otlu B., et al.

GMS HYGIENE AND INFECTION CONTROL , vol.17, 2022 (ESCI) Sustainable Development

30. Sensitivity Affected by Disease Severity and Serum Sampling Time: a Performance Evaluation of Six SARS-CoV-2 Antibody Immunoassays

ŞENER B., KIRBAŞ E., SANCAK B., Gozalan A., EVREN E., KARAHAN Z. C., et al.

JAPANESE JOURNAL OF INFECTIOUS DISEASES , vol.75, no.4, pp.388-394, 2022 (SCI-Expanded, Scopus)

31. A screening study for COVID-19-associated pulmonary aspergillosis in critically ill patients during the third wave of the pandemic

ER B., ER A. G., GÜLMEZ KIVANÇ D., ŞAHİN T. K., HALAÇLI B., DURHAN G., et al.

MYCOSES , vol.65, pp.724-732, 2022 (SCI-Expanded, Scopus) Sustainable Development

32. Is there still a room for improvement in antimicrobial use in a setting where use of broad-spectrum antibiotics require approval of an infectious diseases physician?

Metan G., UZUN Ö., Dizman G., SÖNMEZER M. Ç., İNKAYA A. Ç., HAZIROLAN G., et al.

Infection control and hospital epidemiology , vol.43, no.6, pp.802-804, 2022 (SCI-Expanded, Scopus)

33. Sources of Infection and Risk of COVID-19 for Healthcare Workers at a Tertiary Hospital

Şahan C., Kalaycı D., Erik H. E., Öntaş E., Yıldırım Pak D., Özyürek D., et al.

Erciyes Medical Journal , vol.2022, pp.1-7, 2022 (ESCI, TRDizin) Sustainable Development

34. It is time to define an organizational model for the prevention and management of infections along the surgical pathway: a worldwide cross-sectional survey

Sartelli M., Labricciosa F. M., Coccolini F., Coimbra R., Abu-Zidan F. M., Ansaloni L., et al.

WORLD JOURNAL OF EMERGENCY SURGERY , vol.17, no.1, 2022 (SCI-Expanded, Scopus) Sustainable Development

35. Do antimicrobial stewardship programs improve the quality of care in ICU patients diagnosed with infectious diseases following consultation? Experience in a tertiary care hospital

GÜRSOY G., UZUN Ö., METAN G., YILDIRIM M., BAHAP M., DEMİRKAN S. K., et al.

International Journal of Infectious Diseases , vol.115, pp.201-207, 2022 (SCI-Expanded, Scopus)

36. A COVID-19 first evaluation clinic at a university hospital in Turkey.

Telli Dizman G., Metan G., Ayaz Ceylan Ç. M., Altunay H., Uzun M., Gürsoy G., et al.

Turkish journal of medical sciences , vol.52, no.1, pp.1-10, 2022 (SCI-Expanded, Scopus, TRDizin)

37. Back to the First Days of the Pandemic: How Well Have We Done to Diagnose COVID-19 in Healthcare Workers?

SERTÇELİK A., METAN G., TELLİ DİZMAN G., Atılmış D., Şahan C., KALAYCI D., et al.

FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , vol.27, no.4, pp.555-561, 2022 (TRDizin) Sustainable Development

38. Disseminated Brucella melitensis infection following canakinumab treatment.

Oral H., Sönmezer M. Ç., Yıldız A. E., Hazırolan G., Metan G., İnkaya A. Ç.

Travel medicine and infectious disease , vol.45, pp.102227, 2022 (SCI-Expanded, Scopus)

39. Voriconazole Therapeutic Drug Level Monitoring: A University Hospital Experience

KARA E., BAKIR EKİNCİ P., METAN G., EKİNCİOĞLU A., PINAR A., AKOVA M., et al.

FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , vol.27, no.1, pp.183-188, 2022 (ESCI, TRDizin)

40. Human Ace D/I Polymorphism Could Affect the Clinicobiological Course of COVID-19.

Aladag E., Tas Z., Ozdemir B. S., Akbaba T. H., Akpınar M. G., Goker H., et al.

Journal of the renin-angiotensin-aldosterone system : JRAAS , vol.2021, pp.5509280, 2021 (SCI-Expanded, Scopus)

41. Implementation of Pharmacist-Driven Antifungal Stewardship Program in a Tertiary Care Hospital

KARA E., METAN G., Bayraktar-Ekincioglu A., GÜLMEZ KIVANÇ D., ARIKAN AKDAĞLI S., DEMİRKAZIK F., et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY , vol.65, no.9, 2021 (SCI-Expanded, Scopus) Sustainable Development

42. First Confirmed Cases of 2019 Novel Coronavirus in a University Hospital in Turkey: Housemate Internists

UYAROĞLU O. A., ÇALIK BAŞARAN N., ÖZIŞIK L., TAŞ Z., TELLİ DİZMAN G., İNKAYA A. Ç., et al.

Acta Medica , vol.52, no.1, pp.75-81, 2021 (TRDizin) Sustainable Development

43. Clinical features and outcomes of COVID-19 in patients with solid tumors: Turkish National Registry Data

Ozdemir N., DİZDAR Ö., YAZICI O., AKSOY S., Dede D. S., Budakoglu B., et al.

INTERNATIONAL JOURNAL OF CANCER , vol.148, no.10, pp.2407-2415, 2021 (SCI-Expanded, Scopus) Sustainable Development

44. SARS-CoV-2 Seroprevalence Among Healthcare Workers: Retrospective Analysis of the Data From A University Hospital in Turkey

Özdemir A., Demir Çuha M., Telli Dizman G., Alp A., Metan G., Şener B.

MIKROBIYOLOJI BULTENI , vol.55, no.2, pp.223-232, 2021 (SCI-Expanded, Scopus, TRDizin)

45. First confirmed cases of 2019 Novel Coronavirus in a university hospital in Turkey: housemate internists

Uyaroğlu O. A., ÇALIK BAŞARAN N., ÖZIŞIK L., TAŞ Z., TELLİ DİZMAN G., İNKAYA A. Ç., et al.

Acta Medica , vol.52, no.1, pp.75-81, 2021 (TRDizin)

46. Might Confounding Factors Have an Effect on Suboptimal Dosing of Fluconazole in Critically Ill Patients?

Kara E., Bayraktar Ekincioglu A., Metan G.

Antimicrobial agents and chemotherapy , vol.65, 2021 (SCI-Expanded, Scopus)

47. Colistin Induced Nephrotoxicity: Experience from a University Hospital

Bakır Ekinci P., Kurtaran M., Kara E., Avcı H., Demirkan S. K., Metan G.

Mediterranean Journal of Infection Microbes and Antimicrobials , vol.10, 2021 (Scopus)

48. Outcome of noncritical COVID-19 patients with early hospitalization and early antiviral treatment outside the ICU

Çalik B., Uyaroğlu O., Telli D., Özişik L., Şahin T., Taş Z., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , vol.51, no.2, pp.411-420, 2021 (SCI-Expanded, Scopus, TRDizin)

49. Effects of Cytochrome p450 (CYP) 2C19 Genetic Polymorphisms on Voriconazole Serum Levels: A Report of Two Cases

TAŞ Z., KARA E., DEĞER O., İspirli M., METAN G., BABAOĞLU M. Ö., et al.

Mediterranean Journal of Infection, Microbes and Antimicrobials , vol.10, 2021 (Scopus)

50. Is COVID-19 a risk factor for invasive pulmonary aspergillosis in critically ill patients?

Berrin E. R., Gorkem A. E. R., METAN G., HALAÇLI B., Ersoy E. O., HAZIROLAN G., et al.

TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX , vol.69, no.1, pp.118-120, 2021 (ESCI, Scopus, TRDizin) Sustainable Development

51. Thirty-day readmission rate of COVID-19 patients discharged from a tertiary care university hospital in Turkey: an observational, single-center study

UyaroĞlu O. A., BaŞaran N. Ç., ÖziŞik L., Dİzman G., EroĞlu İ., Şahİn T. K., et al.

INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE , vol.33, no.1, 2021 (SCI-Expanded, SSCI, Scopus)

52. Out-patient management of patients with COVID-19 on home isolation.

Ayaz C. M., Dizman G., Metan G., Alp A., Unal S.

Le infezioni in medicina , vol.28, pp.351-356, 2020 (Scopus) Sustainable Development

53. An Atypical Case with Chronic Granulomatous Disease and Kabuki Syndrome

KÖKER M. Y., Ture Z., Koker N., METAN G.

ERCIYES MEDICAL JOURNAL , vol.42, no.2, pp.229-232, 2020 (ESCI, TRDizin)

54. Emergence of colistin and carbapenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii (CCR-Acb) complex in a neurological intensive care unit followed by successful control of the outbreak

METAN G., Zarakolu P., OTLU B., Tekin I., Aytac H., BÖLEK E. Ç., et al.

JOURNAL OF INFECTION AND PUBLIC HEALTH , vol.13, no.4, pp.564-570, 2020 (SCI-Expanded, Scopus)

55. Neuraminidase Inhibitors and Hospital Length of Stay: A Meta-analysis of Individual Participant Data to Determine Treatment Effectiveness Among Patients Hospitalized With Nonfatal 2009 Pandemic Influenza A(H1N1) Virus Infection

Venkatesan S., Myles P. R., Bolton K. J., Muthuri S. G., Al Khuwaitir T., Anovadiya A. P., et al.

JOURNAL OF INFECTIOUS DISEASES , vol.221, no.3, pp.356-366, 2020 (SCI-Expanded, Scopus)

56. Structural Properties and Performance Test Standards of Surgical Masks with Respirators Used in Healthcare Settings

Zengin H., METAN G., ÜNAL S.

FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , vol.25, no.3, pp.292-300, 2020 (ESCI, TRDizin)

57. The Importance of Awareness for Malaria Regarding Prophylaxis and Early Diagnosis: Two Imported Malaria Cases in Turkey

ÖZMEN ÇAPIN B. B., SÖNMEZER M. Ç., Tortop S., Unalan T., BÖLEK H., ALTINTOP S. E., et al.

MIKROBIYOLOJI BULTENI , vol.53, no.4, pp.472-479, 2019 (SCI-Expanded, Scopus, TRDizin)

58. Is Aspergillus lateral device ready to implement to the daily practice? The question rising from the new European Invasive Aspergillosis management guideline

METAN G.

JOURNAL DE MYCOLOGIE MEDICALE , vol.29, no.1, pp.97-98, 2019 (SCI-Expanded, Scopus)

59. 2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients

Sartelli M., Di Bella S., McFarland L. V., Khanna S., Furuya-Kanamori L., Abuzeid N., et al.

WORLD JOURNAL OF EMERGENCY SURGERY , vol.14, 2019 (SCI-Expanded, Scopus)

60. Galactomannan Antigen Detection as a Screening Tool For Early Diagnosis of Invasive Aspergillosis: Experience of Turkish Adult Patients

METAN G., Akan H.

ERCIYES MEDICAL JOURNAL , vol.40, no.2, pp.57-60, 2018 (ESCI, Scopus, TRDizin)

61. Invasive fungal diseases in patients with acute leukemia or allogeneic stem cell transplantion recepients: A prospective multicenter observational study

METAN G., Etgul S., Cifticioglu A., Saba R., KILIÇ A., Yilmaz H., et al.

MEDICAL MYCOLOGY , vol.56, 2018 (SCI-Expanded, Scopus)

62. Posaconazole prophylaxis in patients with acute myeloid leukemia: A real life experience from a prospective multicenter observational study

METAN G., Etgul S., Cifticioglu A., Saba R., KILIÇ A., Yilmaz H., et al.

MEDICAL MYCOLOGY , vol.56, 2018 (SCI-Expanded, Scopus)

63. Various Antibiotic Combinations Against Carbapenem Resistant Acinetobacter baumannii Infections and In Vitro Synergy Test Results (2002-2016)

Zarakolu P., Ayaz C. M., METAN G.

MIKROBIYOLOJI BULTENI , vol.52, no.2, pp.190-197, 2018 (SCI-Expanded, Scopus, TRDizin) Sustainable Development

64. Cessation of Contact Precautions for Extended-Spectrum Beta-Lactamase (ESBL)-Producing Escherichia coli Seems to be Safe in a Nonepidemic Setting

METAN G., Metin B. C., BAŞTUĞ Z., TEKİN I., AYTAC H., CINAR B., et al.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY , vol.38, no.11, pp.1379-1381, 2017 (SCI-Expanded, Scopus)

65. Therapeutic drug monitorization for voriconazole: Experience from Turkey

METAN G., Kahraman V., KAYNAR L., Karakurkcu M., DEMİR K., Akfirat S., et al.

MYCOSES , vol.60, pp.221, 2017 (SCI-Expanded, Scopus)

66. Is surveillance for colonization of carbapenem-resistant gram-negative bacteria important in adult bone marrow transplantation units?

Demiraslan H., Cevahir F., Berk E., METAN G., ÇETİN M., Alp E.

AMERICAN JOURNAL OF INFECTION CONTROL , vol.45, no.7, pp.735-739, 2017 (SCI-Expanded, Scopus)

67. Performance of Galactomannan Antigen, Beta-D-Glucan, and Aspergillus-Lateral-Flow Device for the Diagnosis of Invasive Aspergillosis

Metan G., KEKLİK M., DİNÇ G., Pala C., Yildirim A., SARAYMEN B., et al.

INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION , vol.33, no.1, pp.87-92, 2017 (SCI-Expanded, Scopus)

68. A Silent Epidemic of Colistin- and Carbapenem-Resistant Enterobacteriaceae at a Turkish University Hospital

Metan G., Ilbay A., Eser O. K., Ünal S., Zarakolu P.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY , vol.38, pp.254-257, 2017 (SCI-Expanded, Scopus)

69. Reducing the impact of carbapenem-resistant Enterobacteriaceae on vulnerable patient groups: what can be done?

METAN G., AKOVA M.

CURRENT OPINION IN INFECTIOUS DISEASES , vol.29, no.6, pp.555-560, 2016 (SCI-Expanded, Scopus)

70. The influence of the control group characteristics for the diagnostic performance of 1,3-beta-D-glucan in invasive aspergillosis

METAN G., Elmali F.

JOURNAL DE MYCOLOGIE MEDICALE , vol.26, no.4, pp.408-410, 2016 (SCI-Expanded, Scopus)

71. Surveillance for Ventilator-Associated Pneumonia: Can We Apply Centers for Disease Control and Prevention National Healthcare Safety Network 2013 Definitions for All Settings?

METAN G., Zengin H., CINAR B., AYTAC H., Hayran M., ÜNAL S.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY , vol.37, no.9, pp.1125-1127, 2016 (SCI-Expanded, Scopus)

72. Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: an individual participant data meta-analysis

Muthuri S. G., Venkatesan S., Myles P. R., Leonardi-Bee J., Lim W. S., Al Mamun A., et al.

INFLUENZA AND OTHER RESPIRATORY VIRUSES , vol.10, no.3, pp.192-204, 2016 (SCI-Expanded, Scopus)

73. Bacterial factors influencing the mortality for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia

ZARAKOLU P., METAN G., Karahan Z. C., Tekeli A., ÜNAL S.

INFECTIOUS DISEASES , vol.48, no.8, pp.649-650, 2016 (SCI-Expanded, Scopus)

74. Tigecycline for the treatment of Clostridium difficile infection refractory to metronidazole in haematopoietic stem cell transplant recipients

Metan G., Ture Z., KAYNAR L., Berk E., GÜRSOY Ş., Alp E., et al.

JOURNAL OF CHEMOTHERAPY , vol.27, no.6, pp.354-357, 2015 (SCI-Expanded, Scopus)

75. Feasibility of a new clinical severity scoring index for Crimean-Congo Hemorrhagic fever*

Kalin G., Metan G., Demiraslan H., DOĞANAY M.

JOURNAL OF CHEMOTHERAPY , vol.27, no.6, pp.353, 2015 (SCI-Expanded, Scopus)

76. A Single Center Experience for Antifungal Prophylaxis in Patients with Acute Myelogenous Leukemia

Metan G., Ture Z., Pala C., KAYNAR L., Yildirim A., Elmali F., et al.

INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION , vol.31, no.3, pp.339-345, 2015 (SCI-Expanded, Scopus)

77. WSES guidelines for management of Clostridium difficile infection in surgical patients

Sartelli M., Malangoni M. A., Abu-Zidan F. M., Griffiths E. A., Di Bella S., McFarland L. V., et al.

WORLD JOURNAL OF EMERGENCY SURGERY , vol.10, 2015 (SCI-Expanded, Scopus)

78. Saprochaete capitata as an emerging fungus among patients with haematological malignencies

Ulu-Kilic A., ATALAY M. A., Metan G., Cevahir F., Koc N., Eser B., et al.

MYCOSES , vol.58, no.8, pp.491-497, 2015 (SCI-Expanded, Scopus)

79. Natural cutaneous anthrax infection, but not vaccination, induces a CD4(+) T cell response involving diverse cytokines

Ingram R. J., Ascough S., Reynolds C. J., Metan G., DOĞANAY M., Baillie L., et al.

CELL AND BIOSCIENCE , vol.5, 2015 (SCI-Expanded, Scopus) Sustainable Development

80. Diagnosis of Invasive Fungal Diseases in Hematological Malignancies: A Critical Review of Evidence and Turkish Expert Opinion (TEO-2)

Akdagli S. A., Azap A., Demirkazik F. B., Ener B., Hayran S. A., Kumbasar O. O., et al.

TURKISH JOURNAL OF HEMATOLOGY , vol.31, no.4, pp.342-356, 2014 (SCI-Expanded, Scopus, TRDizin)

81. Carbapenem-resistant Klebsiella pneumoniae sepsis in corticosteroid receipt mice: tigecycline or colistin monotherapy versus tigecycline/colistin combination

Demiraslan H., DİNÇ G., Ahmed S. S., Elmali F., Metan G., Alp E., et al.

JOURNAL OF CHEMOTHERAPY , vol.26, no.5, pp.276-281, 2014 (SCI-Expanded, Scopus)

82. Do We Really Need Ribavirin in the Treatment of Crimean-Congo Hemorrhagic Fever?

Kalin G., Metan G., Demiraslan H., DOĞANAY M.

JOURNAL OF CHEMOTHERAPY , vol.26, no.3, pp.146-149, 2014 (SCI-Expanded, Scopus)

83. Anthrax Lethal Factor as an Immune Target in Humans and Transgenic Mice and the Impact of HLA Polymorphism on CD4(+) T Cell Immunity

Ascough S., Ingram R. J., Chu K. K., Reynolds C. J., Musson J. A., DOĞANAY M., et al.

PLOS PATHOGENS , vol.10, no.5, 2014 (SCI-Expanded, Scopus)

84. Diarrhea in peripheral stem cell transplant recipients: a developing country's experience

Pala C., KAYNAR L., Buyukoglan R., Kurnaz F., Metan G., Yazar S., et al.

JOURNAL OF INFECTION IN DEVELOPING COUNTRIES , vol.8, no.5, pp.635-641, 2014 (SCI-Expanded, Scopus)

85. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data

Muthuri S. G., Venkatesan S., Myles P. R., Leonardi-Bee J., Al Khuwaitir T. S. A., Al Mamun A., et al.

LANCET RESPIRATORY MEDICINE , vol.2, no.5, pp.395-404, 2014 (SCI-Expanded, Scopus)

86. Outbreak of postoperative empyema caused by Serratia marcescens in a thoracic surgery unit

Ulu-Kilic A., Parkan O., Ersoy S., Koc D., Percin D., ÖNAL Ö., et al.

JOURNAL OF HOSPITAL INFECTION , vol.85, no.3, pp.226-229, 2013 (SCI-Expanded, Scopus)

87. A multidisciplinary team approach to the management of patients with suspected or diagnosed invasive fungal disease

Ben-Ami R., Halaburda K., Klyasova G., Metan G., Torosian T., AKOVA M.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY , vol.68, pp.25-33, 2013 (SCI-Expanded, Scopus)

88. Can low-dose preemptive valganciclovir replace standard intravenous ganciclovir treatment in recipients of allogeneic stem cell transplantation?

KAYNAR L., Metan G., GÖKAHMETOĞLU S., Kurnaz F., Mumcuoglu H., ÖZTÜRK A., et al.

JOURNAL OF CHEMOTHERAPY , vol.25, no.5, pp.286-291, 2013 (SCI-Expanded, Scopus)

89. Evaluation of Imported Plasmodium falciparum Malaria Cases: The Use of Polymerase Chain Reaction in Diagnosis

Demiraslan H., ERDOĞAN E., Ture Z., Kuk S., Yazar S., Metan G.

MIKROBIYOLOJI BULTENI , vol.47, no.4, pp.668-676, 2013 (SCI-Expanded, Scopus, TRDizin) Sustainable Development

90. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease

TUTAR N., Metan G., Koc A. N., YILMAZ İ., Bozkurt I., Simsek Z. O., et al.

MULTIDISCIPLINARY RESPIRATORY MEDICINE , vol.8, 2013 (SCI-Expanded, Scopus)

91. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary diseases

TUTAR N., Metan G., KOÇ A. N., YILMAZ İ., Bozkurt I., Simsek Z. O., et al.

EUROPEAN RESPIRATORY JOURNAL , vol.42, 2013 (SCI-Expanded, Scopus)

92. Exposure to anthrax toxin alters human leucocyte expression of anthrax toxin receptor 1

Ingram R. J., Harris A., Ascough S., Metan G., DOĞANAY M., Ballie L., et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY , vol.173, no.1, pp.84-91, 2013 (SCI-Expanded, Scopus)

93. Clonal diversity and high prevalence of OXA-58 among Acinetobacter baumannii isolates from blood cultures in a tertiary care centre in Turkey

Metan G., Sariguzel F., Sumerkan B., VAN DER REIJDEN T., DIJKSHOORN L.

INFECTION GENETICS AND EVOLUTION , vol.14, pp.92-97, 2013 (SCI-Expanded, Scopus)

94. Factors influencing the early mortality in haematological malignancy patients with nosocomial Gram negative bacilli bacteraemia: a retrospective analysis of 154 cases

Metan G., Demiraslan H., Kaynar L. G., ZARARSIZ G., Alp E., Eser B.

BRAZILIAN JOURNAL OF INFECTIOUS DISEASES , vol.17, no.2, pp.143-149, 2013 (SCI-Expanded, Scopus)

95. Risk factors influencing mortality related to Stenotrophomonas maltophilia infection in hematology-oncology patients

Demiraslan H., Sevim M., Pala C., Durmaz S., Berk V., KAYNAR L., et al.

INTERNATIONAL JOURNAL OF HEMATOLOGY , vol.97, no.3, pp.414-420, 2013 (SCI-Expanded, Scopus) Sustainable Development

96. Diagnosis of Aspergillus niger Peritonitis in a Peritoneal Dialysis Patient by Peritoneal Galactomannan and beta-D-Glucan Detection

Ates O., Metan G., Dundar T., Kiziltepe M., KOÇYİĞİT İ., ÜNAL A., et al.

PERITONEAL DIALYSIS INTERNATIONAL , vol.33, no.2, pp.216-218, 2013 (SCI-Expanded, Scopus)

97. The interaction between piperacillin-tazobactam and Aspergillus galactomannan antigenemia assay: is the story over?

Metan G.

INFECTION , vol.41, no.1, pp.293-294, 2013 (SCI-Expanded, Scopus)

98. Efficacy of Sulbactam and Its Combination with Imipenem, Colistin and Tigecycline in an Experimental Model of Carbapenem-Resistant Acinetobacter baumannii Sepsis

DİNÇ G., Demiraslan H., Elmali F., AHMED S. S., Metan G., Alp E., et al.

CHEMOTHERAPY , vol.59, no.5, pp.325-329, 2013 (SCI-Expanded, Scopus)

99. What is the role of the (1 -> 3)-beta-D-glucan assay in the screening of patients undergoing autologous haematopoietic stem-cell transplantation?

Metan G., KOÇ A. N., KAYNAR L., Atalay A., ÖZTÜRK A., Eser B., et al.

MYCOSES , vol.56, no.1, pp.34-38, 2013 (SCI-Expanded, Scopus) Sustainable Development

100. Bradycardia in a patient with Crimean-Congo hemorrhagic fever related to ribavirin treatment

Uysal B., Metan G.

JOURNAL OF VECTOR BORNE DISEASES , vol.49, no.3, pp.193-194, 2012 (SCI-Expanded, Scopus)

101. Can bacteraemia lead to false positive results in 1,3-beta-D-glucan test? Analysis of 83 bacteraemia episodes in high-risk patients for invasive fungal infections

Metan G., KOÇ A. N., Agkus C., Kaynar L. G., Alp E., Eser B.

REVISTA IBEROAMERICANA DE MICOLOGIA , vol.29, no.3, pp.169-171, 2012 (SCI-Expanded, Scopus)

102. Does ampicillin-sulbactam cause false positivity of (1,3)-beta-D-glucan assay? A prospective evaluation of 15 patients without invasive fungal infections

Metan G., Agkus C., KOÇ A. N., Elmali F., Finkelman M. A.

MYCOSES , vol.55, no.4, pp.366-371, 2012 (SCI-Expanded, Scopus)

103. Comment on "Frequency of Epitope-Specific Naive CD4(+) T Cells Correlates with Immunodominance in the Human Memory Repertoire"

Ascough S., Ingram R. J., Metan G., Maillere B., DOĞANAY M., ÖZKUL Y., et al.

JOURNAL OF IMMUNOLOGY , vol.188, no.11, pp.5205-5206, 2012 (SCI-Expanded, Scopus)

104. A Rare Clinical Presentation and Outcome of Cutaneous Anthrax: Toxemic Shock: Case Report

DOĞANAY M., Metan G.

TURKIYE KLINIKLERI TIP BILIMLERI DERGISI , vol.32, no.3, pp.841-845, 2012 (SCI-Expanded, Scopus)

105. What should be the optimal cut-off of serum 1,3-beta-D-glucan for the detection of invasive pulmonary aspergillosis in patients with haematological malignancies?

Metan G., KOÇ A. N., Atalay A., Kaynar L. G., ÖZTÜRK A., Alp E., et al.

SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES , vol.44, no.5, pp.330-336, 2012 (SCI-Expanded, Scopus) Sustainable Development

106. Intravitreal tigecycline treatment in experimental Acinetobacter baumannii endophthalmitis

Horozoglu F., Metan G., SEVER O., Percin D., TOPAL C. S., GONEN T., et al.

JOURNAL OF CHEMOTHERAPY , vol.24, no.2, pp.101-106, 2012 (SCI-Expanded, Scopus)

107. Naturally Occurring Cutaneous Anthrax: Antibiotic Treatment and Outcome

Kayabas U., Karahocagil M. K., ÖZKURT Z., Metan G., PARLAK E., BAYINDIR Y., et al.

CHEMOTHERAPY , vol.58, no.1, pp.34-43, 2012 (SCI-Expanded, Scopus)

108. Nosocomial candidemia: A threat beyond nosocomial bacterial infections in intensive care units

Mese E. A., Agkus C., Coskun R., Metan G., Koc A. N., SUNGUR M., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , vol.41, no.6, pp.1115-1118, 2011 (SCI-Expanded, Scopus, TRDizin)

109. The peformance of galactomannan antigen assay in the diagnosis of invasive pulmonary aspergillosis at different cutoff values

Metan G., KOÇ A. N., Atalay A., KAYNAR L., ÖZTÜRK A., Alp E., et al.

MYCOSES , vol.54, pp.80-81, 2011 (SCI-Expanded, Scopus)

110. A case of Crimean-Congo haemorrhagic fever successfully treated with therapeutic plasma exchange and ribavirin

Kurnaz F., Metan G., Coskun R., KAYNAR L., Eser B., DOĞANAY M.

TROPICAL DOCTOR , vol.41, no.3, pp.181-182, 2011 (SCI-Expanded, Scopus)

111. Two cases of H1N1 influenza infection as the initial presentation of acute leukemia

KAYNAR L., Sivgin S., Baspinar O., Kurnaz F., Yildirim A., Metan G.

TURKISH JOURNAL OF MEDICAL SCIENCES , vol.41, no.2, pp.363-367, 2011 (SCI-Expanded, Scopus, TRDizin) Sustainable Development

112. Hospitalized pandemic influenza A (H1N1) patients in a university hospital

Metan G., Bozkurt I., Agkus C., Coskun R., Alp E., SUNGUR M., et al.

CENTRAL EUROPEAN JOURNAL OF MEDICINE , vol.6, no.1, pp.83-88, 2011 (SCI-Expanded, Scopus) Sustainable Development

113. A forgotten diagnosis in emergency department: tetanus

Akdur O., Ozkan S., DURUKAN P., Koyuncu M., Ikizceli I., Metan G.

BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY , vol.112, no.8, pp.469-471, 2011 (SCI-Expanded, Scopus) Sustainable Development

114. The interaction between piperacillin/tazobactam and assays for Aspergillus galactomannan and 1,3-beta-d-glucan in patients without risk factors for invasive fungal infections

Metan G., Agkus C., Buldu H., KOÇ A. N.

INFECTION , vol.38, no.3, pp.217-221, 2010 (SCI-Expanded, Scopus)

115. An Epitope of Bacillus anthracis Protective Antigen That Is Cryptic in Rabbits May Be Immunodominant in Humans

Ingram R. J., Chu K. K., Metan G., Maillere B., DOĞANAY M., ÖZKUL Y., et al.

INFECTION AND IMMUNITY , vol.78, no.5, pp.2353, 2010 (SCI-Expanded, Scopus)

116. Clinical Experience with Tigecycline in the Treatment of Carbapenem-Resistant Acinetobacter Infections

Metan G., Alp E., YILDIZ O. G., Percin D., AYGEN B., Sumerkan B.

JOURNAL OF CHEMOTHERAPY , vol.22, no.2, pp.110-114, 2010 (SCI-Expanded, Scopus)

117. Natural Exposure to Cutaneous Anthrax Gives Long-Lasting T Cell Immunity Encompassing Infection-Specific Epitopes

Ingram R. J., Metan G., Maillere B., DOĞANAY M., ÖZKUL Y., Kim L. U., et al.

JOURNAL OF IMMUNOLOGY , vol.184, no.7, pp.3814-3821, 2010 (SCI-Expanded, Scopus)

118. Risk factors for acquisition of methicillin-resistant Staphylococcus aureus and clonal spread of the isolates in a medical intensive care unit

Alp E., Yerer M., Esel D., Metan G., DOĞANAY M.

TURKISH JOURNAL OF MEDICAL SCIENCES , vol.39, no.6, pp.941-951, 2009 (SCI-Expanded, Scopus, TRDizin)

119. The risk factors and spread of multidrug-resistant Acinetobacter baumannii in intubated patients in a medical intensive care unit

Alp E., Yerer M., Kocagoz S., Metan G., Esel D., Guerol Y., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , vol.39, no.5, pp.761-769, 2009 (SCI-Expanded, Scopus, TRDizin)

120. ANTHRAX MENINGOENCEPHALITIS: A CASE REPORT AND REVIEW OF TURKISH LITERATURE

Metan G., Uysal B., Coskun R., Percin D., DOĞANAY M.

MIKROBIYOLOJI BULTENI , vol.43, no.4, pp.671-676, 2009 (SCI-Expanded, Scopus, TRDizin)

121. Antimicrobial susceptibility, inducible macrolide-lincosamide-streptogramin B, and clonal diversity patterns of nosocomial methicillin-resistant Staphylococcus aureus strains isolated in Hacettepe University adult hospital

ZARAKOLU P., Metan G., ALTUN B., HASCELIK G., ÜNAL S.

TURKISH JOURNAL OF MEDICAL SCIENCES , vol.39, no.5, pp.783-789, 2009 (SCI-Expanded, Scopus, TRDizin)

122. Neurobrucellosis: an evaluation of a rare presentation of brucellosis from a tertiary care centre in Central Anatolia, Turkey

Demiraslan H., Metan G., Mese E. A., YILDIZ O., AYGEN B., Sumerkan B., et al.

TROPICAL DOCTOR , vol.39, no.4, pp.233-235, 2009 (SCI-Expanded, Scopus)

123. Factors influencing survival in patients with multi-drug-resistant Acinetobacter bacteraemia

Metan G., Sariguzel F., Sumerkan B.

EUROPEAN JOURNAL OF INTERNAL MEDICINE , vol.20, no.5, pp.540-544, 2009 (SCI-Expanded, Scopus)

124. Predictors of Mortality in Patients with Bacteremia of Unknown Source Due to Extended Spectrum Beta-Lactamase Producing Escherichia coli

Metan G., Altinbas A., Zarakolu P., YILDIZ O. G., Sardan Y. C., Sumerkan B., et al.

JOURNAL OF CHEMOTHERAPY , vol.21, no.4, pp.448-451, 2009 (SCI-Expanded, Scopus)

125. Human Anthrax in Turkey from 1990 to 2007

DOĞANAY M., Metan G.

VECTOR-BORNE AND ZOONOTIC DISEASES , vol.9, no.2, pp.131-139, 2009 (SCI-Expanded, Scopus) Sustainable Development

126. The Antimicrobial Susceptibility of Bacillus anthracis Isolated from Human Cases: A Review of the Turkish Literature

Metan G., DOĞANAY M.

TURKIYE KLINIKLERI TIP BILIMLERI DERGISI , vol.29, no.1, pp.229-235, 2009 (SCI-Expanded, Scopus) Sustainable Development

127. False positivity of 1,3-beta-D-Glucan in patients with gram negative bacilli bacteraemia: presentation of two cases from a tertiary care hospital

Metan M., KOÇ A. N.

MYCOSES , vol.52, pp.43, 2009 (SCI-Expanded, Scopus)

128. Carbapenem resistant Escherichia coli and Klebsiella pneumoniae Isolates from Turkey with OXA 48 Like Carbapenemases and Outer Membrane Protein Loss

GÜLMEZ KIVANÇ D., WOODFORD N., PALEPOU M. I., MUSHTAQ S., METAN G., YAKUPOĞULLARI Y., et al.

International Journal Of Antimicrobial Agents , pp.523, 2008 (SCI-Expanded, SSCI, Scopus)

129. Short communication: Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures

Zarakolu P., Metan G., Hascelik G., Akova M.

MIKROBIYOLOJI BULTENI , vol.41, no.4, pp.579-584, 2007 (SCI-Expanded, Scopus, TRDizin)

130. The frequency of PER-1 type extended spectrum beta-lactamases in nosocomial isolates-of Pseudomonas aeruginosa

ZARAKOLU P., METAN G., AYDİN N. G., ALTUN B., HASÇELİK A. G., AKOVA M.

MIKROBIYOLOJI BULTENI , vol.41, no.3, pp.363-367, 2007 (SCI-Expanded, Scopus, TRDizin)

131. Acinetobacter baumannii meningitis in postneurosurgical patients: clinical outcome and impact of carbapenem resistance

Metan G., ALP E., AYGEN B., SUMERKAN B.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY , vol.60, no.1, pp.197-199, 2007 (SCI-Expanded, Scopus)

132. Carbapenem-resistant Acinetobacter baumannii: an emerging threat for patients with post-neurosurgical meningitis

Metan G., ALP E., AYGEN B., SUMERKAN B.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS , vol.29, no.1, pp.112-113, 2007 (SCI-Expanded, Scopus)

133. Which patient is a candidate for empirical therapy against Stenotrophomonas maltophilia bacteraemia? An analysis of associated risk factors in a tertiary care hospital

Metan G., Hayran M., Hascelik G., Uzun Ö.

SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES , vol.38, pp.527-531, 2006 (SCI-Expanded, Scopus)

134. Brucellosis in all patients with febrile neutropenia

Metan G., Sardan Y., Hascelik G.

LEUKEMIA & LYMPHOMA , vol.47, no.5, pp.954-956, 2006 (SCI-Expanded, Scopus)

135. False positivity for Aspergillus antigenemia related to the administration of piperacillin/tazobactam.

TANRİOVER M., METAN G., ALTUN B., Hascelik G., UZUN Ö.

European journal of internal medicine , vol.16, no.7, pp.489-91, 2005 (Scopus)

136. Rapid detection of antibacterial resistance in emerging Gram-positive cocci

METAN G., ZARAKOLU P., Unal S.

JOURNAL OF HOSPITAL INFECTION , vol.61, no.2, pp.93-99, 2005 (SCI-Expanded, Scopus)

137. Clinical outcomes and therapeutic options of bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli

METAN G., ZARAKOLU P., Cakir B., HASCELIK G., UZUN O.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS , vol.26, no.3, pp.254-257, 2005 (SCI-Expanded, Scopus) Sustainable Development

138. Impact of initial antimicrobial therapy in patients with bloodstream infections caused by Stenotrophomonas maltophilia

Metan G., Uzun Ö.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY , vol.49, no.9, pp.3980-3981, 2005 (SCI-Expanded, Scopus)

139. False positivity for Aspergillus antigenemia with amoxicillin-clavulonic acid

Metan G., Durusu M., Uzun O.

JOURNAL OF CLINICAL MICROBIOLOGY , vol.43, no.5, pp.2548, 2005 (SCI-Expanded, Scopus)

Papers Presented at Peer-Reviewed Scientific Conferences 23

1. SURVEILLANCE FOR INVASIVE PULMONARY ASPERGILLOSIS IN CRITICALLY ILL PATIENTS WITH COVID-19

ER B., ER A. G., GÜLMEZ KIVANÇ D., ŞAHİN T. K., HALAÇLI B., DURHAN G., et al.

18. ULUSAL DAHİLİ VE CERRAHİ BİLİMLER YOĞUN BAKIM E-KONGRESİ VE 10. AVRASYA YOĞUN BAKIM E-TOPLANTISI, Ankara, Turkey, 6 - 09 December 2021, vol.12, (Summary Text) Sustainable Development

2. Saglık çalışanlarında COVID-19 seroprevalansı: Bir ünverste hastanesi verilerinin retrospektif analizi

ÖZDEMİR A., DEMİR M., TELLİ DİZMAN G., ALP A., METAN G., ŞENER B.

TMC 2020 Çevrim İçi Mikrobiyoloji Sempozyumu, 25 December 2020, (Full Text) Sustainable Development

3. COVID-19 YOĞUN BAKIM HASTALARINDA INVAZIV PULMONER ASPERGILLOZIS IÇIN BIR RISK FAKTÖRÜ MÜDÜR?

ER B., ER A. G., METAN G., HALAÇLI B., ORTAÇ ERSOY N. E., HAZIROLAN G., et al.

17. Ulusal Dahili ve Cerrahi Bilimler Yoğun Bakım E-Kongresi ve 9. Avrasya Yoğun Bakım E-Toplantısı, 16 November 2020, (Full Text) Sustainable Development

4. Is COVID-19 a risk factor for invasive pulmonary aspergillosis in critically ill patients?

ER B., ER A. G., METAN G., HALAÇLI B., ORTAÇ ERSOY N. E., HAZIROLAN G., et al.

Türk Dahili Cerrahi Yoğun Bakımlar Derneği 17. Ulusal Kongresi, Turkey, 16 - 18 November 2020, (Summary Text) Sustainable Development

5. The importance of awareness for malaria regarding prophylaxis and early diagnosis: two important malaria cases in Turkey

ÖZMEN ÇAPIN B. B., SÖNMEZER M. Ç., TORTOP s., ÜNALAN E. T., BÖLEK h., ALTINTOP S. E., et al.

XXXVIII. turkish Microbiology Congress, 4 - 08 November 2018, (Full Text) Sustainable Development

6. Cystoisospora belli infection in renal transplant recipient in a university hospital

ÖZMEN ÇAPIN B. B., SÖNMEZER M. Ç., Tortop S., ÜNALAN E. T., Bölek H., ALTINTOP S. E., et al.

Uluslararası 38. Türk Mikrobiyoloji Kongresi, 4 - 08 November 2018, (Summary Text)

7. The İmportance of Awareness for MAlaria Regarding Prophylaxis and Early Diagnosis: Two Imported Malaria Cases in Turkey

ÖZMEN ÇAPIN B. B., SÖNMEZER M. Ç., Tortop S., ÜNALAN E. T., Bölek H., ALTINTOP S. E., et al.

Uluslararası 38. Türk Mikrobiyoloji Kongresi, 4 - 08 November 2018, (Summary Text) Sustainable Development

8. Kan izolatı Lactobacillus rhamnosus dikkate alınmalı mı? Hacettepe Üniversitesi Hastanesinde izole edilen, dünyada ilk kez bildirilen OXA-48 pozitif bir L. rhamnosus olgusu

HAZIROLAN G., GÜNDOĞDU A., ceylan f., METAN G., ALTUN B., GÜR D., et al.

Uluslararası XXXVIII Türk Mikrobiyoloji Kongresi, Starlight Hotel Convention Center, Antalya, Turkey, 4 - 08 November 2018, (Summary Text)

9. Impact of effective antibiptic therapy on mortality in patients with XDR Acinetobacter baumannii bloodstream infections

ZARAKOLU KÖŞKER I. P., AKOVA M., ESER Ö., Özdede M., METAN G.

20th Symposium on Infections in the immunocompromised host, Atina, Greece, 17 - 19 June 2018, (Full Text)

10. Compliance to the guideline of diagnostic tests in febrile neutropenic patients at a Turkish university hospital’

ZARAKOLU KÖŞKER I. P., AKOVA M., BÜYÜKAŞIK Y., DURUSU TANRIÖVER M., DİZDAR Ö., METAN G., et al.

20th Symposium on Infections in the immunocompromised host, Atina, Greece, 17 - 19 June 2018, (Full Text)

11. Emergence of collistin and carbapenem resistant Acinobacter baumannii in neurological intensive care unit

METAN G., ZARAKOLU KÖŞKER I. P., TEKİN I., AYTAÇ h., METİN B. C., ÜNAL S.

28th ECCMID, 21 - 24 April 2018, pp.267, (Full Text)

12. Molecular epidemiology and virulence determinants of Escherichia coli ST131/H30 clone/ subclone among bloodstream isolates

ZARAKOLU KÖŞKER I. P., İLBAY A., METAN G., ESER Ö., gürpınar ö.

28th European Congress of Clinical Microbiology and Infectious Diseases, Madrid, Spain, 21 - 24 April 2018, (Full Text)

13. Emergence of colistin and carbapenem resistant Acinetobacter baumannii in neurological intensive care unit

ZARAKOLU KÖŞKER I. P., ÜNAL S., METAN G., bölek e., aytaç h., metin b., et al.

Proc. 28th European Congress of Clinical Microbiology and Infectious Diseases, p. E0121, p. 267, Madrid, Spain, 2018., Madrid, Spain, 21 - 24 April 2018, (Full Text)

14. Correlation between ST131/H30 Clone/Subclone and Carbapenem-Resistance Genes in Fluoroquinolone Resistant and Sensitive Blood Isolates of Escherichia coli

ESER Ö., ZARAKOLU KÖŞKER I. P., METAN G., İLBAY A., Gürpınar Ö.

27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Vienna, Austria, 22-26 April 2017, 22 April 2017, (Summary Text)

Books 2

1. DENEYİM: PANDEMİDE ÇALIŞAN SAĞLIĞI BİRİMLERİ HACETTEPE ÜNİVERSİTESİ

ŞAHAN C., METAN G., TELLİ DİZMAN G., DURUSU TANRIÖVER M., ÇALIK BAŞARAN N.

in: TTB COVID-19 Pandemisi 6. Ay Değerlendirme Raporu, Türk Tabipler Birliği, Editor, Türk Tabipleri Birliği COVID-19 İzleme Kurulu, Ankara, pp.330-342, 2020

2. Health Technology Assessment Report on the Rapid Molecular Diagnostic Tests Used for Identifying the Causing Agent in the Blood Sample in Sepsis

ÖKSÜZ M. E., MALHAN B. S., ÜNAL S., ARSLAN A. H., METAN G., KAVUNCUBAŞI Ş.

Republic Of Turkey Ministry Of Health, 2019

Metrics

Publication

172

Publication (WoS)

138

Publication (Scopus)

127

Citation (WoS)

2013

H-Index (WoS)

Citation (Scopus)

1936

H-Index (Scopus)

Citation (Scholar)

4335

H-Index (Scholar)

Project

Thesis Advisory

Open Access

UN Sustainable Development Goals

Publications & Works